tiprankstipranks
Advertisement
Advertisement
Summit Therapeutics price target lowered to $16 from $17 at Piper Sandler
PremiumThe FlySummit Therapeutics price target lowered to $16 from $17 at Piper Sandler
5d ago
Summit Therapeutics: Buy/High Risk Rating Reiterated as Analyst Sees Attractive Upside to Unchanged $40 Target Despite HARMONi-3 Interim Miss
Premium
Ratings
Summit Therapeutics: Buy/High Risk Rating Reiterated as Analyst Sees Attractive Upside to Unchanged $40 Target Despite HARMONi-3 Interim Miss
5d ago
Summit Therapeutics price target lowered to $31 from $32 at Clear Street
Premium
The Fly
Summit Therapeutics price target lowered to $31 from $32 at Clear Street
5d ago
Summit partner selection for ASCO ‘likely a major positive,’ says Guggenheim
PremiumThe FlySummit partner selection for ASCO ‘likely a major positive,’ says Guggenheim
15d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
19d ago
Summit Therapeutics to present multiple ivonescimab data sets at ELCC 2026
PremiumThe FlySummit Therapeutics to present multiple ivonescimab data sets at ELCC 2026
1M ago
Summit Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Summit Therapeutics downgraded to Hold from Buy at Jefferies
2M ago
Summit Therapeutics’ Earnings Call Highlights OS Hurdles
Premium
Company Announcements
Summit Therapeutics’ Earnings Call Highlights OS Hurdles
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100